Consumer Healthcare Market (By Product: OTC Pharmaceuticals, Personal Care Products, Dietary Supplements: By Distribution Channel: Online, Offline) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032


The global consumer healthcare market size was reached at USD 284.16 billion in 2022 and it is expected to hit around USD 608.39 billion by 2032, poised to grow at a CAGR of 7.91% during the forecast period from 2023 to 2032.

Consumer Healthcare Market Size 2023 To 2032

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways:

  • North America dominated the market in 2022.
  • Asia Pacific is expected to expand at the fastest CAGR between 2023 and 2032.
  • By product, the OTC pharmaceutical segment dominated the market with the highest market share of 47% in 2022.
  • By Distribution Channel, the offline segment captured more than 80% of revenue share in 2022.
  • By Distribution Channel, the online segment will grow at a remarkable CAGR.

Consumer Healthcare Market Overview:

Consumer healthcare is seen as one of the emerging segments of the healthcare industry. The consumer healthcare market generally offers numerous healthcare services and products where decisions about purchase and usage are taken by the consumers without requiring any specific prescription from the healthcare professional. The major patient base offered to the global consumer healthcare market is the one seeking for pain relief, nutrition and wellness and overall health improvement products in the form of drugs, supplements or powders.

The consumer healthcare market covers the development and distribution of over the counter drugs and vitamins, herbal products, ayurvedic products and multiple health supplements. The consumer healthcare market is expanding due to the innovation in the upcoming new technologies such as tech wearables and wellness and fitness services. The global consumer healthcare market is again supported by the rising awareness about healthcare solutions, early diagnosis of diseases and intervention of multiple healthcare platforms, especially online platforms. The availability of medical content on online platforms and digital channels promotes the growth of the market.

Growth Factors:

The increasing costs of healthcare services and the rising pressure on healthcare professionals or staff during the emergencies like pandemic has boosted the demand for consumer healthcare solutions from the overall healthcare sector in recent years. Increasing demand for patient-centric treatments and improvements in the healthcare infrastructure will result in the growth of the consumer healthcare market in the forecast period. Moreover, the booming digitization in the healthcare industry is seen as another growth factor in the global consumer healthcare market.

The Covid-19 pandemic majorly contributed to the growth of the consumer healthcare market across the world. The pandemic had a significant impact on the consumption of healthcare services. For instance, the sale of Vitamin C and preventive drugs doubled in 2022. The increase in online channels for the purchase of medicines in healthcare services is observed to be expanding continuously since the pandemic, the element contributes to the growth of the market.

The market has witnessed a major challenge associated with the reach and expansion in underdeveloped areas. However, the rising education and awareness about healthcare systems and services in these areas has started addressing the challenge. The growth of the market is mainly attributed to the rising population across the world and rise in the chronic diseases will highly contribute to the demand for the consumer healthcare market.

Consumer Healthcare Market Scope

Report Coverage Details
Market Size in 2023 USD 306.64 Billion
Market Size by 2032 USD 608.39 Billion
Growth Rate from 2023 to 2032 CAGR of 7.91%
Largest Market North America
Base Year 2022
Forecast Period 2023 To 2032
Segments Covered By Product and By Distribution Channel
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Consumer Healthcare Market Dynamics:

Driver:

The rapid adoption of telehealth and telemedicine

To ensure social isolation, many healthcare systems throughout the world have adopted telemedicine since the outbreak of Coronavirus. Since the time of pandemic, patients have started seeking virtual healthcare which is increasing at an unprecedented rate in China, the United States, and Europe. Several digital healthcare platforms are available in European countries to meet this demand. The growing popularity of online platforms for healthcare advice has provided a definite platform for consumer healthcare product distributors for marketing their products according to the patients’ requirement. Many of these distributors are collaborating with healthcare professionals to meet the desired consumer base. This element offers an opportunity for the innovation of consumer healthcare products by driving the growth of the market.

Restraint:

Issues with expansion in underdeveloped areas

The major challenge for the expansion of the consumer healthcare market is caused due to the lack of awareness about underlying health conditions among people. In underdeveloped areas or regions, lack of adequate healthcare infrastructure and weaker economies often create obstacles for the consumer healthcare market players to distribute products and services. Moreover, shortage of digitized solutions and lack of knowledge about online healthcare platforms also limit people from adopting such products. The expansion of the market is also limited in such areas due to skepticism about the consumption of new products. Thus, the factor is observed to hamper the market’s growth.

Opportunity:

Booming e-commerce platforms

The availability of consumer healthcare products on online platforms or e-commerce sites is offering massive opportunities for the market. For consumer healthcare organizations, new digital opportunities across every aspect of the value chain, such as increasing e-commerce channels, have set up new routes for reaching new client groups and reinforcing current ones. Multiple supplementary items have seen increased purchasing rates across e-commerce channels as digital medical and health website traffic and online orders have increased dramatically.

Major pharmacy stores have already introduced omnichannel retailing initiatives, integrating their physical and digital sales channels to provide consumers with additional options, the advantages of shopping on these platforms include door-step delivery, a wider product selection, potentially reduced costs due to fewer overheads compared to physical stores, and freedom from pharmacy store pressure. Thus, booming e-commerce businesses are observed to offer opportunities for the consumer healthcare market to grow.

Product Insights:

The OTC pharmaceutical segment dominated the market with the highest market share in 2022, the segment is expected to grow at a significant rate during the forecast period. The increasing tendency of self-medication in the population will result in the growth of the segment. OTC refers to over-the-counter medicines or it is also referred to as nonprescription medicines. These medicines are generally taken without prescription, it is completely safe and should be taken according to the guidance of the physicians and the direction written on the label. The increasing use of OTC drugs by the consumer due to easy availability and rising use of self-medication driving the growth of the segment.

Consumer Healthcare Market Share, By Product, 2022 (%)

On the other hand, the personal care segment is expected to witness a notable rate of growth during the forecast period. The growth of the segment is attributed due to the rising awareness about the personal care and rising beauty standards among consumers. Moreover, the rising number of appearance-conscious consumers across the globe is observed to be a major factor behind the expansion of the segment.

Distribution Channel Insights:

The offline segment dominated the market with the highest revenue size in 2022. The easy availability of healthcare products at pharmacies or stores drives the growth of the segment, the use of the offline healthcare segment as the traditional type in the healthcare industry has supported the segment to expand. Moreover, the offline pharmacies and stores have achieved consumer trust which is happened to be the major factor behind the segment’s dominance.

Consumer Healthcare Market Share, By Distribution Channel, 2022 (%)

The online segment is expected to grow at a notable rate during the forecast period. The rising availability of online platforms for pharmaceutical and other healthcare products across the globe, especially in urban areas is driving the growth of the segment. The online platforms offering healthcare products and services aggregate the information about the product, schedule an appointment for telemedicine advice, and delivers products to the consumers. The overall growth of e-commerce industry will present multiple opportunities for the segment’s growth.

Regional Insights:

North America held the largest share of the market in 2022, the region is expected to sustain its dominance throughout the forecast period. The market’s growth is attribute to the increasing awareness about dietary supplements and nutrition and wellness products in the region. Moreover, multiple healthcare professionals and associated agencies have recognized the importance of consumption of supplementary products, this element supports the market’s expansion in North America.

In addition, the overall presence of strong regulatory framework for the research and developments of consumer healthcare products has supplemented the growth of the market in North America. Manufacturers and distributors of dietary supplements and ingredients in the United States are bind with multiple strict guidelines, this promotes the distribution of reliable products in the country while achieving consumer trust.

The United States-based, consumer healthcare Products Association stated in May 2023, the US Food and Drug Administration has approved the over-the-counter nasal spray, Narcan. The Association applauded the approval by FDA for the product to be available for public without any prescription which was previously available on only prescription basis.

Asia Pacific is expected to grow at a significant rate during the forecast period. The rising population, growing health issues and rising awareness about health among the population promote the growth of the market in the region. Moreover, the presence of multiple potential players to invest in research and development of consumer healthcare products will supplement the growth of the market.

Asia Pacific, especially India is a home to multiple herbal and organic products since the ancient period. The availability of ingredients for herbal healthcare products and the potential for research and development for the same is attracting major investors, local and international in the market.

The booming e-commerce industry in the region promotes the distribution of consumer healthcare products in Asia Pacific, which is observed to act as a major driver for the market’s expansion in the upcoming years. The presence of a geriatric population with multiple health conditions, especially deficiencies has force healthcare professionals to consider consumer healthcare products as a supplementary solution for ageing population. This element contributes to the market’s growth.

Recent Developments:

  • In July 2023, a medical tourism network platform “Caremedico” announced its official launch, access to the network for over 300 healthacare instiutions, 5000 skilled doctors, 1000 technologies, these launch will provide the complex healthacare services to the patients from Bangladesh and India.
  • In Aug 2023, the new online health clinic was launched by the Amazon Inc. which is available for the entire United States. The e-commerce company’s vision to provide the services through its mobile app or website.
  • In Aug 2023, FMCG brands Mamaearth and The Derma Co., and healthcare tech firm Indegene Ltd. owns by the company Honasa Consumer Ltd., received the SEBI’s permission to raise the funds by the Initial Public Offerings (IPO’s).
  • In July 2023, the major pharmaceutical industry “Cipla” announced the launch of respiratory drug at the end of the qaurter and early in next quarter and expecting 2 to 3% growth in the revenue from new products in the forecast year 2024.
  • In Aug 2023, the Department of Older Persons and Yaphrom signed the MOU the Memorandum of Understanding for support of Thailand’s transition to smart ageing society to launch its new Yaphrom 60+. The launch will offer an access for the free medical consultation and medication with the pharmacist and teaches to how to cure and take care of the congenital, chronic diseases, and illness on time.

Consumer Healthcare Market Companies

  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Amway Corp.
  • Bayer AG
  • BASF SE
  • Abbott Laboratories
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Segments Covered in the Report:

By Product 

  • OTC Pharmaceuticals
  • Personal Care Products
  • Dietary Supplements

By Distribution Channel

  • Online
  • Offline

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

What is the consumer healthcare market size?
The global consumer healthcare market size was valued at USD 608.39 billion in 2022 and it is expected to surpass around USD 284.16 billion by 2032.
What will be the CAGR of global consumer healthcare market?
The global consumer healthcare market will register growth rate of 7.91% between 2023 and 2032.
Who are the prominent players operating in the consumer healthcare market?
The major players operating in the consumer healthcare market are Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson, GlaxoSmithKline plc, Sanofi S.A., Amway Corp., Bayer AG, BASF SE, Abbott Laboratories, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, and Others.
Which are the driving factors of the consumer healthcare market?
The driving factors of the consumer healthcare market are the rapid adoption of telehealth and telemedicine, the increasing costs of healthcare services, and the rising pressure on healthcare professionals or staff.
Which region will lead the global consumer healthcare market?
North America region will lead the global consumer healthcare market during the forecast period 2023 to 2032.

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample